HLHaowen Li

Haowen Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haowen Li has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • Chengya Dong

    Clinical Medical Research Laboratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

    2 shared publications
  • Fanhong Kong

    Beijing Tiantan Hospital, Beijing, China

    2 shared publications
  • Haoxiao Chang

    China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

    2 shared publications
  • Jingli Cao

    Clinical Medical Research Laboratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

    2 shared publications
  • Li Liu

    Clinical Medical Research Laboratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

    2 shared publications
  • Lijun Liu

    Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

    2 shared publications

Latest Publications

  • Open Access

    Increased serum phenylalanine and tyrosine concentration related to inflammation in patients with primary angiitis of the central nervous system

    by Ning Feng, Jing Wang-Chang, Fen Wu, Han Su, Yaobo Zhao, Lina Sun, Shunfeng Zhao, Haoxiao Chang, Haowen Li

  • Open Access

    Multiple sclerosis and type 1 diabetes: a Mendelian randomization study of European ancestry

    by Jing Wang-Chang, Jia Ma, Han Su, Xiaoqiang Wu, Shunfeng Zhao, Yuan Cai, Ning Feng, Lina Sun, Xin Zhao, Kai Feng, et al.

    Objectives: Observational studies have indicated that type 1 diabetes (T1D) is prevalent in multiple sclerosis (MS), yet the causality remains unclear. The purpose of this study was to assess the causal association between MS and T1D. Methods: We employed a Mendelian randomization method using two samples to research the causal association between MS and T1D. The study primarily utilized the inverse variance weighted (IVW) method, and we use three methods (MR Egger, Weighted median, Weighted mode) for auxiliary analysis. To avoid reverse causality, we employed the Steiger Test method to further examine the screened SNPs. Furthermore, sensitivity analysis was conducted to ensure the robustness of the obtained results. Results: When MS was considered as the exposure variable and T1D as the outcome variable, the results indicated a significant positive correlation (IVW, OR=1.078, 95 % CI: 1.041−1.117; p<0.001). Conversely, when T1D is the exposure in question, the causal relationship with MS remains undetermined. These results were further validated through sensitivity analysis. Conclusions: The MR analysis results indicate that there is a causal relationship between MS and T1D. We provide compelling genetic evidence to support the causal connection between MS and an increased risk of T1D.


  • Open Access

    A Potent Antagonist of Smoothened in Hedgehog Signaling for Epilepsy

    by Junwan Fan, Zichen Zhao, Ru Liu, Haowen Li, Wenyan He, Jianping Wu, Yongjun Wang, Wei Chen

    Epilepsy is one of the common encephalopathies caused by sudden abnormal discharges of neurons in the brain. About 30% of patients with epilepsy are insensitive and refractory to existing antiseizure medications. The sonic hedgehog signaling pathway is essential to the development and homeostasis of brain. Aberrant sonic hedgehog signaling is increased in refractory epileptic lesions and may involve the etiology of epilepsy. Thus, new inhibitors of Smoothened, a key signal transducer of this signaling pathway are urgently need for refractory epilepsy. We have established a high-throughput screening platform and discovered several active small molecules targeting Smoothened including TT22. Here we show that the novel Smoothened inhibitor TT22 could block the translocation of βarrestin2-GFP to Smoothened, reduce the accumulation of Smoothened on primary cilia, displace Bodipy-cyclopamine binding to Smoothened, and inhibit the expression of downstream Gli transcription factor. Moreover, TT22 inhibits the abnormal seizure-like activity in neurons. Furthermore, we demonstrated that FDA-approved Smoothened inhibitor GDC-0449 and LDE-225 are able to inhibit abnormal seizure-like activity in neurons. Thus, our study suggests that targeting the sonic hedgehog signaling with new small-molecule Smoothened inhibitors might provide a potential new therapeutic avenue for refractory epilepsy.


  • Open Access

    Establishment and quality evaluation of a glioma biobank in Beijing Tiantan Hospital

    by Fanhong Kong, Wenli Zhang, Lin Qiao, Qi Li, Haowen Li, Jingli Cao, Wenyan He, Chengya Dong, Yanjiao He, Lu He, et al.

    Background: We established a glioma biobank at Beijing Tiantan Hospital in November, 2010.Specialized staffs have been trained to collect, store and manage the biobank in accordance with standard operating procedures. Methods: One hundred samples were selected to evaluate the quality of glioma samples stored in the liquid nitrogen tank during different periods (from 2011 to 2015) by morphological examination, RNA integrity determination, DNA integrity determination, housekeeping gene expression and protein integrity determination. Results: The majority of samples (95%) remain high RNA quality for further analysis with RIN≥6. All samples remain high DNA and protein quality without significant degradation. Conclusion: Storage conditions of our biobank are suitable for long-term (at least 5 years) sample preservation with high molecular quality.

  • Open Access

    Establishment and quality evaluation of a glioma biobank in Beijing Tiantan Hospital

    by Fanhong Kong, Wenli Zhang, Lin Qiao, Qi Li, Haowen Li, Jingli Cao, Wenyan He, Chengya Dong, Yanjiao He, Lu He, et al.

    Background: We established a glioma biobank at Beijing Tiantan Hospital in November, 2010.Specialized staffs have been trained to collect, store and manage the biobank in accordance with standard operating procedures. Methods: One hundred samples were selected to evaluate the quality of glioma samples stored in the liquid nitrogen tank during different periods (from 2011 to 2015) by morphological examination, RNA integrity determination, DNA integrity determination, housekeeping gene expression and protein integrity determination. Results: The majority of samples (95%) remain high RNA quality for further analysis with RIN≥6. All samples remain high DNA and protein quality without significant degradation. Conclusion: Storage conditions of our biobank are suitable for long-term (at least 5 years) sample preservation with high molecular quality.